Provided by Tiger Trade Technology Pte. Ltd.

CITIUS ONCOLOGY INC

0.7632
-0.0124-1.60%
Pre-market: 0.7600-0.0032-0.42%07:49 EDT
Volume:38.71K
Turnover:30.19K
Market Cap:70.96M
PE:-1.55
High:0.8200
Open:0.8200
Low:0.7529
Close:0.7756
52wk High:2.25
52wk Low:0.4912
Shares:92.98M
Float Shares:18.20M
Volume Ratio:0.98
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4931
EPS(LYR):-0.3380
ROE:-126.58%
ROA:-29.12%
PB:1.76
PE(LYR):-2.26

Loading ...

Company Profile

Company Name:
CITIUS ONCOLOGY INC
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
11 Commerce Drive,First Floor,Cranford,New Jersey,United States
Zip Code:
07016
Fax:
- -
Introduction:
TenX Keane Acquisition focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on target businesses operating in Asia, excluding companies located or operating in mainland China, Hong Kong, or Macau. The company was incorporated in 2021 and is based in New York, New York.

Directors

Name
Position
Leonard Mazur
Chairman of the Board, Chief Executive Officer and Director
Carol Webb
Independent Director
Dennis M. McGrath
Independent Director
Eugene Holuka
Independent Director
Joel Mayersohn
Independent Director
Jonathan Peri
Independent Director
Myron Holubiak
Director and Secretary
Robert J. Smith
Independent Director
Suren Dutia
Independent Director and Lead Independent Director

Shareholders

Name
Position
Leonard Mazur
Chairman of the Board, Chief Executive Officer and Director
Jaime Bartushak
Chief Business Officer and Chief Financial Officer
Myron Holubiak
Director and Secretary
Myron S. Czuczman
Chief Medical Officer and Executive Vice President